SCHEMBL7664997

SCHEMBL7664997

CCCCC(NC(=O)c1ccc(OCc2ccc3ccccc3c2)cc1)C(=O)CNC(=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.51
ALOX5 P09917 1/20 0.47
NPC1 O15118 2/20 0.46
MAPT P10636 1/20 0.46
PTPN2 P17706 1/20 0.45
CDC25B P30305 1/20 0.45
CCKBR P32239 1/20 0.45
CTSL P07711 2/20 0.45
CTSS P25774 2/20 0.45
CTSB P07858 1/20 0.45
CTSK P43235 1/20 0.45
MEN1 O00255 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
PLG P00747 1/20 0.44
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
PRSS3 P35030 1/20 0.44
DHFR P00374 1/20 0.44
FPGS Q05932 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7385051 0.93 PTPN1 (0.46) PTPN1ALOX5NPC1MAPTPTPN2
SCHEMBL7420467 0.87 PTPN1 (0.45) PTPN1ALOX5NPC1MAPTPTPN2
SCHEMBL7678439 0.87 ADAMTS4 (0.48) PTPN1NPC1MAPTCCKBRDHFR
SCHEMBL7696969 0.87 PTPN1 (0.56) PTPN1ALOX5NPC1MAPTPTPN2
SCHEMBL7661370 0.84 CCKBR (0.44) MAPTCCKBRCTSLCTSSCTSB
SCHEMBL7659961 0.82 MEN1 (0.52) NPC1MAPTCCKBRMEN1RAB9A
SCHEMBL7694848 0.81 PTPN1 (0.55) PTPN1ALOX5NPC1MAPTPTPN2
SCHEMBL7665000 0.78 ALDH1A1 (0.52) CCKBRMEN1KMT2AHDAC3HDAC1
SCHEMBL7666410 0.77 CCKBR (0.42) NPC1MAPTCCKBRCTSLCTSS
SCHEMBL7702953 0.76 PTPN1 (0.53) PTPN1NPC1MAPTPTPN2CDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed